Federal pharmacist Paxlovid prescribing authority: A model policy or impediment to optimal care?

The U.S federal government leveraged emergency authority to allow pharmacists to prescribe Paxlovid (nirmatrelvir and ritonavir) during the COVID-19 pandemic. While heralded by pharmacy associations, the FDA framework included restrictions that arguably ran counter to clinical guidelines and evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Alex J., Eid, Deeb D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011027/
https://www.ncbi.nlm.nih.gov/pubmed/36945228
http://dx.doi.org/10.1016/j.rcsop.2023.100244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011027/
https://www.ncbi.nlm.nih.gov/pubmed/36945228
http://dx.doi.org/10.1016/j.rcsop.2023.100244

Ejemplares similares